chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore throat; goes to the bathroom more often for bowel movements; felt tired; felt lightheaded; broke out in sweats; rash that was light pink; swollen; urinates less at night; sleeps longer with more "deep sleep" and more "REM"; had "side effects"; "couldn't walk in straight line"; lightheaded, dizzy; Fever 99F; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (had "side effects"), GAIT DISTURBANCE ("couldn't walk in straight line"), DIZZINESS (lightheaded, dizzy), PERIPHERAL SWELLING (swollen) and DIZZINESS (felt lightheaded) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy and Drug allergy (oxycontin).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced ADVERSE REACTION (had "side effects"), GAIT DISTURBANCE ("couldn't walk in straight line"), DIZZINESS (lightheaded, dizzy) and PYREXIA (Fever 99F). On 12-Mar-2021, the patient experienced PERIPHERAL SWELLING (swollen), OLIGURIA (urinates less at night) and SOMNOLENCE (sleeps longer with more "deep sleep" and more "REM"). On 13-Mar-2021, the patient experienced RASH (rash that was light pink). On 14-Mar-2021, the patient experienced DIZZINESS (felt lightheaded) and HYPERHIDROSIS (broke out in sweats). On 17-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), BOWEL MOVEMENT IRREGULARITY (goes to the bathroom more often for bowel movements) and FATIGUE (felt tired). At the time of the report, ADVERSE REACTION (had "side effects"), GAIT DISTURBANCE ("couldn't walk in straight line"), DIZZINESS (lightheaded, dizzy), PERIPHERAL SWELLING (swollen), DIZZINESS (felt lightheaded), HYPERHIDROSIS (broke out in sweats), OROPHARYNGEAL PAIN (sore throat), BOWEL MOVEMENT IRREGULARITY (goes to the bathroom more often for bowel movements), OLIGURIA (urinates less at night), SOMNOLENCE (sleeps longer with more "deep sleep" and more "REM"), FATIGUE (felt tired), RASH (rash that was light pink) and PYREXIA (Fever 99F) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99 99F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Left arm raised, red, warm to touch. Redness from shoulder to elbow. Hard bump under her skin aprox 1-1.5 inches wide by 1 inch long. Pt had body aches especially her large joints (elbows and knees). Pt was off from work for a week.
pt recv vax;stiff w/head back;not breathing;shaking;turning blue;mouth to mouth per mom,pt v;seems unresponsive;to er;whining/crying;sl cold;febrile convuls;OT;gastroenteritis;artificial resp,color nl but glossy stare;adm for observation;
DTaP, IPV, Comvax, Prevnar given 06/26/02 at 9:00. On next day, irritable, poor appetite, poor tone. 06/27/02 at 18:00, lost any control staring and unresponsive for 10 minutes.
Information has been received from a consumer concerning one of her female baby who on approximately 09-MAR-2009 (*three weeks ago*) was vaccinated with ATTENUVAX. On approximately 16-MAR-2009 (7 days after receiving ATTENUVAX) the patient throw up for a couple of days and had fever. This is one of two reports from the same source. Additional information has been requested.
Presented with chest pain and diagnosed with  my and pericarditis as evidenced by elevated troponin, , elevated BNP and diffuse ST changes on EKG
Kinrix instead of Vaxelis; Patient was administered Kinrix on 04-JAN-22; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 7-month-old male patient who received DTPa-IPV (Kinrix) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 1st April 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 1st April 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 4-May-2022 Reporter's comment: Medical assistant reported that the patient was administered Kinrix vaccine instead of the Vaxelis vaccine. The reporter consented to follow-up. Additional Supportive Information: The patient received Kinrix vaccine at an inappropriate age instead of Vaxelis vaccine, which led to wrong vaccine administered and inappropriate age at vaccine administration.
Information has been received from a nurse referring to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, concomitant medication and medical history were not provided. On unknown dates the patients received unspecified doses of improperly stored ZOSTAVAX (lot# L017165, expiry date 13-AUG-2016; lot# L036823, expiry date 24-DEC-2016; dose and route were unspecified). Excursion details; Temperature/Time frame: 12F/3 hours. There was a previous temperature excursion: 22F/60 minutes. This report was not because of a "data logger". No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Narrative: COVID infections following completion of COVID vaccine series 04/27/21 COVID vaccine dose #1 05/18/21 COVID vaccine dose #2 07/29/21 Pt presents to screening reporting headache and runny nose for 2 days and reports close exposure to COVID positive person; COVID POSITIVE 07/30/21 PT reports chills, cough, fatigue, headache, muscle pain, runny nose, sore throat that started 07/24; rx given for acetaminophen, DM/guaifenesin, throat lozenges 07/31/21 Pt reports loss of taste/smell 08/01/21 Pt reports cough, headache, and runny nose but is stable 08/02/21 Pt reports dry cough, headache, muscle pain, and runny nose; states some bleeding while blowing nose - advised to not blow as hard and using salt water mist 08/03/21 Pt denies cough but reports muscle pain, runny nose, congestion, sneezing bu is improving 08/04/21 Pt reports fatigue and runny nose; clinically fesolved
Patient was in her car seat, after grandparents had come out of the grocery store.  Grandparents noted child was twitching.  Unresponsive & had some drool.  She was taken to the ER.  The doctor examined, ran a test.  See # 12.  Child was unresponsive whole episode.  Child was monitored.  Shows no adverse effects at this time.
Headache, swollen axilliary node, malaise, 6 days early menstrual period. Narrative:
22Feb89 pt vax w/ hepta B; devel n/v/d, dizziness, hot flashes, + sore arm.  3 days later sx resolved except for nausea which lasted 3 more days. 20Oct89 vax w/ 2nd hepta B; exp n/ + dizziness.  Tx w/ Rx drug.
This spontaneous report as received from a pharmacist refers to a 69 year old female patient with type 2 diabetes and hypertension. There were no drug reactions/allergies. On 06-MAY-2014 the patient was vaccinated with a dose of ZOSTAVAX lot # J011335, expiration date December 2014, 0.65 ml, subcutaneous. Concomitant therapy included unspecified oral medications for type 2 diabetes and hypertension. On an unknown date in 2014 the patient experienced "rash on her belly". The patient sought medical attention via visiting physician's office and calling to pharmacy. The outcome of the event was unknown. Additional information has been requested.
The next day I started feeling feverish. I started to experience aches and it triggered my arthritis. The fever was never high, but lasted all day. Around 9pm, I started experienced pressure in my chest. By 11pm, it had extended from neck to my throat. I took Pepcid. The next morning, I only felt it around my heart. I monitored the pain throughout the following day and I was advised to go to Urgent care/ER. I went on Monday and was told they couldn't do anything and I should go to the ER. I was given baby aspirin and kept me overnight. I also had a high BP. It gradually improved and I started feeling better about 8 hours after they started treatment. I was held for observation and was released the following day after my ultrasound. I was told by my cardiologist to take baby aspirin and to increase my water intake before the second dose. I only experienced fever and aches, but it only lasted over the weekend. I only took Tylenol.
headache, severe joint aches, sudden stomach cramping & diarrhea, feeling of nausea, fatigue
Case was vaccinated for Covid by June 2021, then was hospitalized for Covid in February of 2022. Hospitalized at:  Local Community Hospital. Case presented to hospital with recent history of cough, and increased confusion/forgetfulness.  Treated for Toxic metabolic encephalopathy r/t Covid, and discharged home.
Quarter size swelling, hot, itchy, soreness and redness at injection site. Treating with ice and Ibuprofen. Symptoms greater than a week after injection.
High blood pressure 177/111. weakness in legs and arms.  dizziness. can't get up from sitting position or laying position. if on the floor, can't get up from that position.  Outcome: most adverse events ended about 2 and 1/2 days later. Adverse event started about 1 to 2 hours after injection.
Pt has injection 3/21 (L) deltoid got pain down left arm and developed weakness of (L) hand grip pain persisted x-ray neg for abscess or hematoma. Pt given VICODIN pain weakness persists. Pt for (L) shoulder ordered.
given an expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 60-year-old female patient who received HAV (Havrix) (batch number unknown, expiry date 11th September 2021) for prophylaxis.   On 14th September 2021, the patient received Havrix. On 14th September 2021, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were reported as follows: This case was reported by the nurse. The age at vaccination was not reported. The nurse reported that a patient had been given an expired dose of Havrix on 14th September 2021 and vaccine expiration date was 11th September 2021,which led to expired vaccine used. The nurse reported that no more information available to reporter since the information had been given to them by someone else. The reporter consented to follow-up.
too young to get Moderna, family aware and will follow up with peds for guidance on second dose.
SEVERE HEADACHE; FEVER; TIRED; This spontaneous report received from a consumer concerned a 43 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, and expiry: 23-JUN-2021) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, treatment medications included: ibuprofen. On 12-APR-2021, the subject experienced severe headache. On 12-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced tired. Laboratory data included: Body temperature (NR: not provided) 102 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, and had not recovered from severe headache, and tired. This report was non-serious.
The patient was administered a volume of 0.25mL instead of the appropriate volume of 0.5mL. The error was recognized the following day and outreach was made to Moderna and CDC for clinical recommendations for the next step. Upon response from the clinical team 9 days later the patient was informed of the error and was given the direction to return to the pharmacy at as soon as possible to receive a complete dose of 0.5mL. No adverse events had been reported. Complete dose was administered on 9-19-22
Information has been received from a pharmacist concerning a patient of unknown age and sex. The patient's pertinent medical history and drug allergies were not reported. On an unspecified date, the patient was vaccinated with a dose of PNEUMOVAX23 (dose, route and frequency were not reported) (lot # and expiration date were not reported). It was reported that on an unknown date patient "asked the pharmacist what an injection site reaction was" since she patient experienced some type of reaction below the injection site, unspecified what type of reaction, unspecified what site. It was unknown if patient sought medical attention. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Feb. 6 I got the second dose, 3 weeks later I was diagnosed with A-fib. In the first couple of days in March. I saw Dr, for the A-fib diagnose, I switch to Dr. due to him bein an electrophysiologist.
Experiencing significant hairloss; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient. A 65 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Oct2021 09:00 (Lot number: FF2590) at the age of 65 years as dose 3, single for covid-19 immunisation. Relevant medical history included: "Osteopenia" (unspecified if ongoing); "Penicillin" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]. Past drug history included: Aspirin, reaction(s): "known allergies: Aspirin". Vaccination history included: Bnt162b2 (dose 2, single, Batch/Lot No: EP8737, Location of injection: Arm Left, Vaccine Administration Time: 09:00 AM), administration date: 12Apr2021, for Covid-19 Immunization; Bnt162b2 (dose 1, single, Batch/Lot No: 6204, Location of injection: Arm Left, Vaccine Administration Time: 09:00 AM), administration date: 17Mar2021, for Covid-19 Immunization. The following information was reported: ALOPECIA (non-serious) with onset 25Oct2021 06:00, outcome "not recovered", described as "Experiencing significant hairloss". Therapeutic measures were not taken as a result of alopecia.  Additional information: No if other vaccine in four weeks. Adverse event: Experiencing significant hair loss. Large clump of hair found about 3" wide after waking this morning on 25Oct21. Have been experiencing hair loss after washing hair for a couple of months now. This recent event was the most significant event. No if covid prior vaccination. No if covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
2 month old patient accidentally vaccinated with PNEUMOVAX23; No adverse event; This spontaneous report was received from a physician assistant, who is also the patient's mother, reporting about a 2-month-old male patient. The patient's concurrent conditions and medcial history, as well as concomitant medications, were not reported.  On an unknown date, the patient was accidentally vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) for prophylaxis (strength, dose, route, frequency, lot# and expiration date were not provided). No adverse events were reported.
Patient complained of left arm swelling, redness and itching. Patient was advised to go to the Emergency Department since it was a Sunday. He said he would call his Doctor the next day.
This spontaneous prospective pregnancy report as received from a nurse and refers to a currently 18 year old female patient. There was no concurrent conditions or medical history and it was unknown if the patient had concomitant therapies. On 26-JAN-2018, the patient was vaccinated with her third dose of GARDASIL 9 (concentration, dose, route and anatomical place of vaccination were not reported), with a lot # N021733 and expiration date of 01-FEB-2020, for prophylaxis. On 27-JAN-2018, an urine and blood test confirmed that the patient was pregnant; it was unknown if the patient received any kind of treatment or if she sought medical attention. The last menstrual period (LMP) and estimated date of delivery (EDD) were not known. The pregnancy outcome was pending.
This case involves three patients (unknown age and gender) who had pneumonia, after receiving INFLUENZA VACCINE. It was unknown if the patients had any medical history, concomitant disease or risk factor. Medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On an unknown date, the patients received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date were not reported) via unknown route in an unknown administration site for prophylactic vaccination. On an unknown date, the patients developed serious pneumonia (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant and was leading to death. It was unknown if the patient experienced any additional symptoms/ events. It was unknown if there were lab data/results available. It was not reported if the patient received a corrective treatment. Three friends died in 2018 from pneumonia. It was unknown if an autopsy was done. Information on the batch number was requested.; Sender's Comments: This case involves patients who had pneumonia, after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset is unknown. It was unknown if an autopsy was done. Further information regarding their past medical conditions, previous vaccination tolerance and other laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of a suspect vaccine cannot be assessed.; Reported Cause(s) of Death: pneumonia
2 16 year old twin boys, received TRUMENBA shot. 8 hours later they ran a 102.0 fever lasting 24 hours. They also said the skin on their back, head and arms felt raw but looked normal. They broke out in hives 12 hours after the shot.
This spontaneous report was received from a registered nurse regarding a 64 year old patient of unknown gender. The patient's medical history, concurrent conditions, drug allergies or concomitant therapies were not reported. On 28-MAR-2017, the patient was inadvertently vaccinated with an expired dose of PNEUMOVAX 23 (strength and dose were not reported) administered intramuscularly (lot number: L019836; expiration date: 24-MAR-2017) for prophylaxis. No adverse effects were reported. Additional information has been requested.
She noted her arm was more sore than the first time; She noted her arm was more sore than the first time; This is a spontaneous report from a contactable consumer, the patient. A female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: EL9261 and expiry date: May2021) via an unspecified route of administration on 28Jan2021 (yesterday) as single dose for COVID-19 immunization. Patient's medical history and concomitant medications were not reported. Patient previously took first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: EL1284 and expiry date: Apr2021) and felt pressure between eyes, was slightly dizzy, had hangover feeling, and arm was hurt. About 10 hours later, patient's arm was sorer than the first time. She was feeling fine today Events were recovering.  Information on the lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.
Had Hep A #2 09/04/2003 and immediately reported pain in left arm.  Swelling left arm began approximately 3 days later with some itching.  Saw MD 11/19/03 and told not to use arm or work. Vaccinated in Mexico and saw MD there and was given meds.  Saw MD in NV 12/19/03 and had x-rays taken.  Had MD visit in NV 01/09/04 and given meds Flexaril, Meloxi cam, aspercreme.  Told "no problem with x-rays. No diagnosis.  Pain and shaking in left arm continues.  Client states and indicated to nurse she received infection in shoulder joint. Client attributed administration to nurse not documented as administrator.
No addittional adverse effects reported; MMR II that underwent temperature excursions was administered; This spontaneous report was received from an unspecified reporter referring to a patient of unknown age and gender. The patient's medical history, previous drug reactions or allergies, and concomitant therapies were not reported.  On 13-DEC-2021, it was administered therapy with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) for prophylaxis (lot number T033814 had been verified to be a valid number; expiration date: 05-OCT-2022; strength, dose, route of administration, and anatomical location were not provided) that underwent temperature excursion (product storage error). It was reported the temperature excursion was above 9 degrees Celsius (C) (12.4C) for a time frame of 0 hours, 53 minutes and 0 seconds; above 9 degrees C (9.6C) for a time frame of 0 hours, 34 minutes and 0 seconds; above 9 degrees C (9.5C) for a time frame of 0 hours, 23 minutes and 0 seconds; and above 9 degrees C (8.5C) for a time frame of 0 hours, 9 minutes and 0 seconds. It was reported that no had previous temperature excursion. No additional adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2112USA006870:
Received injection early Aug. 2015 immediately felt pain in left arm. For approx. 1 week (L) arm felt "dead" in AM and could not lift arm in morning. Pain/stiffness/loss in mobility/hurts to sleep on left side/experiencing continued pain, stiffness, headaches/effecting neck. Treatment Pilates, PT, chiropractor, massage. Pain continues/radiating pain at injection site too.
has soreness and hurting at the injection site; right arm pain and burning getting pretty unbearable; from arm down to forearm; right arm pain and burning getting pretty unbearable; from arm down to forearm; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in right arm on 13Apr2021 (Lot Number: ER8731) as SINGLE DOSE for COVID-19 immunization. The patient's medical history was none and concomitant medications were not reported.  On 13Apr2021, the patient experienced soreness and hurting at the injection site and mentioned right arm pain and burning getting pretty unbearable; and that pain was radiating from arm down to forearm. Tylenol and Advil were considered as therapeutic measures. The outcome was not recovered for the reported events.  No follow-up attempts are needed. No further information is expected.
I received my booster of Moderna at 12:30pm. I went to bed at 8:30 because I was very tired. I woke up at 11:30pm and was very nauseous, clammy, hot/cold, sweating, shaky. I then began projectile vomiting. I also began having diarrhea simultaneously. This went on until 1:30am. I was finally able to settle around 2:30am and have not had any vomiting or diarrhea since.
Itchy rash on legs primarily on front of legs which gets worse when prone or in the bathtub. Still occurring 13 days after 2nd vaccine.